Type 2 Diabetes

A recent study found that patients with type 2 diabetes who used a GLP-1 receptor agonist for more than 1 year had an increased risk for thyroid cancer compared with non-users.

Nearly half of a cohort of adults with type 2 diabetes participating in a calorie-restricted intermittent fasting intervention achieved diabetes remission, according to findings from a randomized controlled trial in China.

The risk for incident type 1 or type 2 diabetes increases after a COVID-19 infection, according to findings from a systematic review and meta-analysis published in Metabolism: Clinical and Experimental.

Adults with type 2 diabetes experienced more confidence and involvement in self-managing their disease when they had an adult friend or family supporter present, researchers reported.

The FDA has granted clearance to a next-generation continuous glucose monitoring system for people with all types of diabetes aged 2 years and older, according to a press release.

A phase 3 trial of empagliflozin demonstrated statistically significant HbA1c reduction among children and adolescents aged 10 to 17 years with type 2 diabetes, according to a press release from Eli Lilly.

Type 2 diabetes rates and associated number of years lost due to poor health, disability or early death increased substantially among adolescents and young adults from 1990 to 2019, particularly in low- and low-middle income countries.

Adults with type 2 diabetes who use a GLP-1 receptor agonist for more than 1 year may have an increased risk for thyroid cancer, according to findings published in Diabetes Care.

Applying optimal defaults to online grocery shopping resulted in the promotion of healthier grocery purchases among adults with or at risk for type 2 diabetes, researchers reported in Obesity.

Adults with an elevated level of pancreatic fat have higher risk for developing incident diabetes, but weight loss may be able to lower diabetes risk by reducing fat levels and increasing pancreatic volume, according to a presenter.